Michielon Elisabetta, Motta Alexandre C, Ogien Jonas, Oranje Paul, Waaijman Taco, Thakoersing Varsha, Veldhorst Sanne, de Gruijl Tanja D, Gibbs Susan
Department of Molecular Cell Biology and Immunology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Amsterdam institute for Infection and Immunity, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology Program, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.
IMcoMET, Rotterdam, the Netherlands.
J Dermatol Sci. 2024 Aug;115(2):85-93. doi: 10.1016/j.jdermsci.2024.07.001. Epub 2024 Jul 10.
In tissue engineering, real-time monitoring of tumors and of the dynamics of the microenvironment within in vitro models has traditionally been hindered by the need to harvest the cultures to obtain material to analyze. Line-field confocal optical coherence tomography (LC-OCT) has proven to be useful in evaluating in vivo skin conditions, including melanoma, by capturing dynamic, three-dimensional (3D) information without the need for invasive procedures, such as biopsies. Additionally, the M-Duo Technology® developed by IMcoMET presents a unique opportunity for continuous in situ biomarker sampling, providing insights into local cellular behavior and interactions.
This study aimed to validate the non-destructive mapping capabilities of two advanced methodologies (LC-OCT by DAMAE Medical and M-Duo Technology® by IMcoMET) to investigate the living microenvironment of in vitro reconstructed human skin (RhS) and melanoma-RhS (Mel-RhS).
LC-OCT and M-Duo Technology® were compared to conventional analysis of the RhS and Mel-RhS microenvironments.
LC-OCT successfully visualized the distinct layers of the epidermis and tumor structures within the Mel-RhS, identifying keratinocytes, melanocytes, tumor nests, and fibroblasts. The M-Duo Technology® revealed differences in in situ cytokine (IL-6) and chemokine (CCL2, CXCL10, and IL-8) secretion between Mel-RhS and the control RhS. Notably, such differences were not detected through conventional investigation of secreted proteins in culture supernatants.
The combination of LC-OCT's high-resolution imaging and M-Duo Technology®'s in situ microenvironmental mapping has the potential to provide a synergistic platform for non-invasive, real-time analysis, allowing for prolonged observation of processes within Mel-RhS models without the need for culture disruption.
在组织工程中,传统上对体外模型内肿瘤及微环境动态进行实时监测一直受到阻碍,因为需要收获培养物以获取分析材料。线场共焦光学相干断层扫描(LC - OCT)已被证明可用于评估包括黑色素瘤在内的体内皮肤状况,它无需活检等侵入性程序即可获取动态三维(3D)信息。此外,IMcoMET公司开发的M - Duo Technology®提供了连续原位生物标志物采样的独特机会,有助于深入了解局部细胞行为和相互作用。
本研究旨在验证两种先进方法(DAMAE Medical公司的LC - OCT和IMcoMET公司的M - Duo Technology®)对体外重建人皮肤(RhS)和黑色素瘤 - RhS(Mel - RhS)活体微环境进行无损测绘的能力。
将LC - OCT和M - Duo Technology®与RhS和Mel - RhS微环境的传统分析方法进行比较。
LC - OCT成功可视化了Mel - RhS内表皮的不同层次和肿瘤结构,识别出角质形成细胞、黑素细胞、肿瘤巢和成纤维细胞。M - Duo Technology®揭示了Mel - RhS与对照RhS之间原位细胞因子(IL - 6)和趋化因子(CCL2、CXCL10和IL - 8)分泌的差异。值得注意的是,通过对培养上清液中分泌蛋白的传统研究未检测到此类差异。
LC - OCT的高分辨率成像与M - Duo Technology®的原位微环境测绘相结合,有可能提供一个协同的平台用于无创实时分析,无需破坏培养即可对Mel - RhS模型内的过程进行长时间观察。